We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
+65.77%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
10 Year Est. Return
AUM
$910M
AUM Growth
Cap. Flow
+$703M
Cap. Flow %
77.21%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLK
1
DELISTED
Allakos
ALLK
$805M 88.44%
+5,750,506
New +$598M
SPRB
2
Spruce Biosciences
SPRB
$175M
$52.2M 5.74%
+28,644
New +$47.5M
MIRM icon
3
Mirum Pharmaceuticals
MIRM
$5.94B
$33.5M 3.68%
+1,921,118
New +$37.8M
VAPO
4
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$16.3M 1.79%
+75,622
New +$16.9M
OTIC
5
DELISTED
Otonomy, Inc.
OTIC
$3.25M 0.36%
+501,899
New +$2.28M

Similar funds

RiverVest Venture Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for RiverVest Venture Management, which disclosed 5 positions worth $910M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Allakos: 5,750,506 shares worth $805M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • RiverVest Venture Management's largest Q4 2020 buy was Allakos: 5,750,506 shares worth $805M.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $910M portfolio in Q4 2020.
  • RiverVest Venture Management disclosed 5 positions in Q4 2020, its first 13F filing on record.

Based on RiverVest Venture Management's 13F filing for Q4 2020, filed 11 Aug 2021.